Showing results (1-10 of 4,701) with videos related to
Sort By:
Pageof 471
Therapeutic Drug Monitoring|January 1, 1985
Interference with high performance liquid chromatographic chloramphenicol assay in a patient receiving dobutamineM B Powel, C A Robinson, R L FurnerTherapeutic Drug Monitoring|January 1, 1985
Fallacious results from measuring salivary carbamazepine concentrationsR G Dickinson, W D Hooper, A R King, et al.Therapeutic Drug Monitoring|September 21, 2022
Donor-Derived Cell-free DNA for Personalized Immunosuppression in Renal TransplantationMichael Oellerich, Klemens Budde, Bilgin Osmanodja, et al.Therapeutic Drug Monitoring|January 1, 1986
Plasma nor1-chlorpromazine concentrations: effects of age, race, and sexR C YoungTherapeutic Drug Monitoring|January 1, 1986
Factors influencing theophylline disposition in 179 newbornsJ T Gilman, P Gal, R S Levine, et al.Therapeutic Drug Monitoring|January 1, 1986
Simultaneous measurement of bupivacaine, etidocaine, lidocaine, meperidine, mepivacaine, and methadoneD E Coyle, D D DensonTherapeutic Drug Monitoring|January 1, 1979
Comparison of three assay procedures for theophylline determinationI S Kampa, L K Dunikoski, J I Jarzabek, et al.Therapeutic Drug Monitoring|October 17, 2022
Impact of ABCC2 1249G>A and -24C>T Polymorphisms on Lacosamide Efficacy and Plasma Concentrations in Uygur Pediatric Patients With Epilepsy in ChinaTing Zhao, Hong-Jian Li, Hui-Lan Zhang, et al.Therapeutic Drug Monitoring|December 20, 2014
Generation of a Highly Specific Monoclonal Anti-Infliximab Antibody for Harmonization of TNF-Coated Infliximab AssaysThomas Van Stappen, Els Brouwers, Sophie Tops, et al.Therapeutic Drug Monitoring|November 11, 2014
Plasma Methylphenidate Levels in Youths With Attention Deficit Hyperactivity Disorder Treated With OROS FormulationOzgur Yorbik, Caner Mutlu, Selma Ozilhan, et al.Pageof 471